Matches in Wikidata for { <http://www.wikidata.org/entity/Q57812786> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- Q57812786 description "artículu científicu espublizáu n'ochobre de 2018" @default.
- Q57812786 description "im Oktober 2018 veröffentlicher wissenschaftlicher Artikel" @default.
- Q57812786 description "scientific article published on 19 October 2018" @default.
- Q57812786 description "wetenschappelijk artikel" @default.
- Q57812786 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q57812786 name "Corrigendum to "Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's antiseizure efficacy" [Neuropharmacology 143 (2018) 186-204]" @default.
- Q57812786 name "Corrigendum to "Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's antiseizure efficacy" [Neuropharmacology 143 (2018) 186-204]" @default.
- Q57812786 type Item @default.
- Q57812786 label "Corrigendum to "Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's antiseizure efficacy" [Neuropharmacology 143 (2018) 186-204]" @default.
- Q57812786 label "Corrigendum to "Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's antiseizure efficacy" [Neuropharmacology 143 (2018) 186-204]" @default.
- Q57812786 prefLabel "Corrigendum to "Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's antiseizure efficacy" [Neuropharmacology 143 (2018) 186-204]" @default.
- Q57812786 prefLabel "Corrigendum to "Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's antiseizure efficacy" [Neuropharmacology 143 (2018) 186-204]" @default.
- Q57812786 P1104 Q57812786-D5BBD00E-B44A-40D2-9C22-92B019959236 @default.
- Q57812786 P1433 Q57812786-AA328139-0586-4231-988E-F081B1DD3EDE @default.
- Q57812786 P1476 Q57812786-267956D1-3B09-44FA-ACB6-4D38F88A013C @default.
- Q57812786 P2093 Q57812786-04EC7FFD-9CFE-4B4F-B39A-15D3C5E826C7 @default.
- Q57812786 P2093 Q57812786-2F84CE5D-C0B8-452F-BCE7-637CCE536A37 @default.
- Q57812786 P2093 Q57812786-30B58DC5-D66C-4D84-A663-DAE0AD54C7C5 @default.
- Q57812786 P2093 Q57812786-35D7DBA4-7E0A-4B15-82D9-EDEA5CF7AF00 @default.
- Q57812786 P2093 Q57812786-46084FE0-68EE-4D9B-8B1C-5E79809E4344 @default.
- Q57812786 P2093 Q57812786-5B82C4FC-712D-495C-B3C9-C515A7E9B11E @default.
- Q57812786 P2093 Q57812786-7EBA2B08-1E33-4630-8277-BB25E10C7011 @default.
- Q57812786 P2093 Q57812786-8B482C99-BBA4-4BFA-A56C-8B5D82657CCC @default.
- Q57812786 P2093 Q57812786-8ECA760B-7F10-4F7F-8D73-53923A560803 @default.
- Q57812786 P2093 Q57812786-9F9EB256-FAD6-4D91-BC62-0B3A79DE8E1F @default.
- Q57812786 P2093 Q57812786-A5AEC686-7DB4-4B8A-A4C0-E8D3155B007B @default.
- Q57812786 P2093 Q57812786-B2F0F15E-5FD6-402A-BA10-3E03A951438C @default.
- Q57812786 P2093 Q57812786-B6C993A2-7ADC-41DF-8AD2-1B40118BEFBA @default.
- Q57812786 P2093 Q57812786-D323AC26-028F-443E-B749-35704854C4B3 @default.
- Q57812786 P304 Q57812786-F97AAE15-B2E7-4161-B6FB-060D28D05CBB @default.
- Q57812786 P31 Q57812786-342D857D-EAB5-470F-8DB7-7F88084AAB64 @default.
- Q57812786 P31 Q57812786-9E3DFA72-426F-4E23-85FE-A25230B4F9B7 @default.
- Q57812786 P356 Q57812786-64A97D98-1836-4D1C-B910-10FEB1B5AC46 @default.
- Q57812786 P407 Q57812786-DAAD8CC8-3EEF-4716-A03F-33F1D7438494 @default.
- Q57812786 P478 Q57812786-1D8C1463-60F2-4F47-95F2-E3D2F1EB605A @default.
- Q57812786 P50 Q57812786-326D4571-C00D-44D2-9B07-E9DCB38CBAEE @default.
- Q57812786 P50 Q57812786-C7DFBBA3-7EBC-4140-A640-C87C057D14C9 @default.
- Q57812786 P577 Q57812786-0B6C0C02-05FB-4FFA-95A8-AC27072DAAAB @default.
- Q57812786 P698 Q57812786-A78DFA02-6E8E-4C91-BFA8-B1A8A70F9AB4 @default.
- Q57812786 P921 Q57812786-BBF116E8-4379-463E-A81F-9D3EC7E76FA2 @default.
- Q57812786 P356 J.NEUROPHARM.2018.10.012 @default.
- Q57812786 P698 30343990 @default.
- Q57812786 P1104 "+2" @default.
- Q57812786 P1433 Q15332439 @default.
- Q57812786 P1476 "Corrigendum to "Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's antiseizure efficacy" [Neuropharmacology 143 (2018) 186-204]" @default.
- Q57812786 P2093 "Andi Kipper" @default.
- Q57812786 P2093 "Claudia Brandt" @default.
- Q57812786 P2093 "Inkeri Spoljaric" @default.
- Q57812786 P2093 "Kasper Lykke" @default.
- Q57812786 P2093 "Kathrin Töllner" @default.
- Q57812786 P2093 "Kerstin Römermann" @default.
- Q57812786 P2093 "Markus Kalesse" @default.
- Q57812786 P2093 "Martin Puskarjov" @default.
- Q57812786 P2093 "Nanna MacAulay" @default.
- Q57812786 P2093 "Patricia Seja" @default.
- Q57812786 P2093 "Pauliina Paavilainen" @default.
- Q57812786 P2093 "Peter W Feit" @default.
- Q57812786 P2093 "Trine Lisberg Toft-Bertelsen" @default.
- Q57812786 P2093 "Wolfgang Löscher" @default.
- Q57812786 P304 "349-350" @default.
- Q57812786 P31 Q13442814 @default.
- Q57812786 P31 Q1348305 @default.
- Q57812786 P356 "10.1016/J.NEUROPHARM.2018.10.012" @default.
- Q57812786 P407 Q1860 @default.
- Q57812786 P478 "143" @default.
- Q57812786 P50 Q16299558 @default.
- Q57812786 P50 Q89261540 @default.
- Q57812786 P577 "2018-10-19T00:00:00Z" @default.
- Q57812786 P698 "30343990" @default.
- Q57812786 P921 Q3026765 @default.